Hidden

Other Indications

We are actively working on leveraging the VersaTM platform to develop sustained-release formulations of drugs for the following indications:

-Acromegaly

-Alzheimer’s

-Breast cancer

-Chemotherapy-induced pain and vomiting

-Parkinson’s

It is well known that the market potential for each of the above mentioned disease indications is multi-million.